fenofibrate has been researched along with Central Hypothyroidism in 12 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with hypothyroidism who presented with rhabdomyolysis during fenofibrate monotherapy for hypertriglyceridemia was reported." | 8.98 | Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review. ( Wang, D; Wang, Y, 2018) |
| "Hypothyroidism is one of the common causes of the secondary hypercholesterolemia." | 6.43 | [Fenofibrate--induced myopathy in a patient with undiagnosed hypothyroidism--case report and a review of the literature]. ( Brzosko, M; Lukjanowicz, M; Trzcińska-Butkiewicz, B, 2006) |
| "Subclinical hypothyroidism is suggested to increase cardiovascular risk." | 5.40 | Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidism. ( Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W, 2014) |
| "A patient with hypothyroidism who presented with rhabdomyolysis during fenofibrate monotherapy for hypertriglyceridemia was reported." | 4.98 | Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review. ( Wang, D; Wang, Y, 2018) |
| " We hereby report a patient proved to be a case of unrecognized hypothyroidism presenting with rhabdomyolytic acute renal failure precipitated by the combined use of statin and fenofibrate." | 3.73 | A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism. ( Alici, T; Colak, HB; Kursat, S, 2005) |
| "Hypothyroidism is one of the common causes of the secondary hypercholesterolemia." | 2.43 | [Fenofibrate--induced myopathy in a patient with undiagnosed hypothyroidism--case report and a review of the literature]. ( Brzosko, M; Lukjanowicz, M; Trzcińska-Butkiewicz, B, 2006) |
| "Subclinical hypothyroidism is suggested to increase cardiovascular risk." | 1.40 | Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidism. ( Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W, 2014) |
| "Primary hypothyroidism and type 2 diabetes are both typically associated with the increased level of triglycerides." | 1.33 | A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas. ( Chang, SH; Chung, SI; Hahm, JR; Jung, JH; Jung, TS; Kim, DR; Kim, MA; Lee, GW; Park, JR; Park, KJ, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Grasser, LR | 1 |
| Saad, B | 1 |
| Bazzi, C | 1 |
| Wanna, C | 1 |
| Abu Suhaiban, H | 1 |
| Mammo, D | 1 |
| Jovanovic, T | 1 |
| Javanbakht, A | 1 |
| Miceli, DD | 1 |
| Guevara, JM | 1 |
| Ferraris, S | 1 |
| Pignataro, OP | 1 |
| Gallelli, MF | 1 |
| Ramadhan, ZR | 1 |
| Poerwoprajitno, AR | 1 |
| Cheong, S | 1 |
| Webster, RF | 1 |
| Kumar, PV | 1 |
| Cychy, S | 1 |
| Gloag, L | 1 |
| Benedetti, TM | 1 |
| Marjo, CE | 1 |
| Muhler, M | 1 |
| Wang, DW | 1 |
| Gooding, JJ | 1 |
| Schuhmann, W | 1 |
| Tilley, RD | 1 |
| Wang, D | 1 |
| Wang, Y | 1 |
| Losacco, MC | 1 |
| de Almeida, CFT | 1 |
| Hijo, AHT | 1 |
| Bargi-Souza, P | 1 |
| Gama, P | 1 |
| Nunes, MT | 1 |
| Goulart-Silva, F | 1 |
| Krysiak, R | 1 |
| Gilowski, W | 1 |
| Szkrobka, W | 1 |
| Okopien, B | 1 |
| Sousa, AA | 1 |
| Kronit, HS | 1 |
| Neves, Fde A | 1 |
| Amato, AA | 1 |
| Park, JR | 1 |
| Jung, TS | 1 |
| Jung, JH | 1 |
| Lee, GW | 1 |
| Kim, MA | 1 |
| Park, KJ | 1 |
| Kim, DR | 1 |
| Chang, SH | 1 |
| Chung, SI | 1 |
| Hahm, JR | 1 |
| Kursat, S | 1 |
| Alici, T | 1 |
| Colak, HB | 1 |
| Lukjanowicz, M | 1 |
| Trzcińska-Butkiewicz, B | 1 |
| Brzosko, M | 1 |
| Satarasinghe, RL | 1 |
| Ramesh, R | 1 |
| Riyaaz, AA | 1 |
| Gunarathne, PA | 1 |
| de Silva, AP | 1 |
| Schlienger, JL | 1 |
| Goichot, B | 1 |
| Grunenberger, F | 1 |
| Pradignac, A | 1 |
| Cherif, O | 1 |
| Karma, F | 1 |
| Ben Amor, G | 1 |
| Kochbati, S | 1 |
| Ben Amor, B | 1 |
| Rokbani, L | 1 |
| Clouâtre, Y | 1 |
| Leblanc, M | 1 |
| Ouimet, D | 1 |
| Pichette, V | 1 |
3 reviews available for fenofibrate and Central Hypothyroidism
| Article | Year |
|---|---|
Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.
Topics: Adult; Female; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Hypothyroidism; Rhab | 2018 |
[Fenofibrate--induced myopathy in a patient with undiagnosed hypothyroidism--case report and a review of the literature].
Topics: Contraindications; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Male; | 2006 |
Hypothyroidism is a predisposing factor for fenofibrate-induced rhabdomyolysis--patient report and literature review.
Topics: Acute Kidney Injury; Aged; Fenofibrate; Humans; Hypolipidemic Agents; Hypothyroidism; Male; Muscles; | 2007 |
9 other studies available for fenofibrate and Central Hypothyroidism
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Biomarkers; Cat Diseases; Catalysis; Cats; Child; Emotions; Fenofibrate; | 2022 |
High-fat diet affects gut nutrients transporters in hypo and hyperthyroid mice by PPAR-a independent mechanism.
Topics: Animals; Antithyroid Agents; Diet, High-Fat; Fenofibrate; Glucose Tolerance Test; Hyperthyroidism; H | 2018 |
Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidism.
Topics: Adult; Aged; C-Reactive Protein; Cardiotoxicity; Cardiovascular Diseases; Dyslipidemias; Female; Fen | 2014 |
Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism.
Topics: Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Hypothyroidism; Male; Middle Aged; | 2009 |
A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas.
Topics: Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fenofibrate; Humans; Hyperlipidemias; Hy | 2005 |
A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism.
Topics: Acute Kidney Injury; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-C | 2005 |
[Thyroid myopathy disclosed by a fibrate].
Topics: Aged; Fenofibrate; Humans; Hypolipidemic Agents; Hypothyroidism; Male; Rhabdomyolysis | 1997 |
[Hypothyroidism and muscular toxicity from fenofibrate, report of a case revealed by polymyositis].
Topics: Female; Fenofibrate; Humans; Hypolipidemic Agents; Hypothyroidism; Middle Aged; Polymyositis | 1997 |
Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism.
Topics: Acute Kidney Injury; Female; Fenofibrate; Humans; Hypolipidemic Agents; Hypothyroidism; Middle Aged; | 1999 |